Acadian Asset Management
VMD icon

Acadian Asset Management’s Viemed Healthcare VMD Stock Holding History

Acadian Asset Management’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Buy
165,287
+132,045
+397% +$1.1M ﹤0.01% 1036
2025
Q4 		$246K Buy
33,242
+1,028
+3% +$7.04K ﹤0.01% 1477
2025
Q3 		$217K Buy
32,214
+2,798
+10% +$18.9K ﹤0.01% 1385
2025
Q2 		$203K Sell
29,416
-7,050
-19% -$47.9K ﹤0.01% 1305
2025
Q1 		$265K Hold
36,466
– – ﹤0.01% 1200
2024
Q4 		$292K Sell
36,466
-8,869
-20% -$76.9K ﹤0.01% 1187
2024
Q3 		$331K Sell
45,335
-212,086
-82% -$1.52M ﹤0.01% 1199
2024
Q2 		$1.68M Sell
257,421
-197,136
-43% -$1.49M 0.01% 827
2024
Q1 		$4.27M Sell
454,557
-216,580
-32% -$1.86M 0.01% 510
2023
Q4 		$5.29M Sell
671,137
-129,789
-16% -$942K 0.02% 433
2023
Q3 		$5.37M Sell
800,926
-46,778
-6% -$383K 0.02% 417
2023
Q2 		$8.28M Buy
847,704
+127,413
+18% +$1.29M 0.03% 333
2023
Q1 		$6.93M Buy
720,291
+45,127
+7% +$393K 0.03% 378
2022
Q4 		$5.1M Hold
675,164
– – 0.03% 438
2022
Q3 		$4.07M Buy
675,164
+37,577
+6% +$241K 0.02% 455
2022
Q2 		$3.44M Sell
637,587
-291,829
-31% -$1.57M 0.02% 502
2022
Q1 		$4.66M Sell
929,416
-190,943
-17% -$887K 0.02% 479
2021
Q4 		$5.83M Sell
1,120,359
-217,092
-16% -$1.21M 0.02% 422
2021
Q3 		$7.41M Sell
1,337,451
-230,812
-15% -$1.5M 0.03% 369
2021
Q2 		$11.2M Buy
1,568,263
+19,057
+1% +$165K 0.04% 306
2021
Q1 		$15.8M Sell
1,549,206
-7,481
-0.5% -$70.4K 0.06% 254
2020
Q4 		$12.2M Sell
1,556,687
-523
-0% -$4.6K 0.05% 302
2020
Q3 		$13.5M Buy
1,557,210
+276,420
+22% +$2.79M 0.06% 267
2020
Q2 		$12.2M Sell
1,280,790
-126,825
-9% -$986K 0.05% 296
2020
Q1 		$6.54M Sell
1,407,615
-95,705
-6% -$475K 0.04% 340
2019
Q4 		$9.42M Buy
1,503,320
+30,236
+2% +$210K 0.04% 322
2019
Q3 		$10.2M Buy
+1,473,084
New +$9.82M 0.04% 334

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Acadian Asset Management's VMD Position: Q1 2026 in Review

Acadian Asset Management increased its Viemed Healthcare (VMD) stake by 397% in Q1 2026, buying an estimated $1.1M and bringing the position to 165,287 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Acadian Asset Management first reported a position in VMD in Q3 2019 and has held it in 27 quarters since. The position peaked at $15.8M in Q1 2021. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Acadian Asset Management held 165,287 shares of Viemed Healthcare worth $1.52M as of Q1 2026.
  • Acadian Asset Management bought 132,045 Viemed Healthcare shares in Q1 2026, an estimated $1.1M.
  • Viemed Healthcare made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1036 holding.
  • Acadian Asset Management first reported a position in Viemed Healthcare in Q3 2019 and has held it in 27 quarters since.
  • Acadian Asset Management's Viemed Healthcare position peaked at $15.8M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.